Zobrazeno 1 - 10
of 396
pro vyhledávání: '"Greig, Ja"'
Autor:
Werner MS; Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA., Aras S; Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA., Morgan AR; Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA., Roamer J; Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA., Param NJ; Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA., Olagbegi K; Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA., Lamontagne RJ; Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA., Greig JA; Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA., Wilson JM; Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA. wilsonjm@upenn.edu.
Publikováno v:
Cancer gene therapy [Cancer Gene Ther] 2024 May; Vol. 31 (5), pp. 766-777. Date of Electronic Publication: 2024 Mar 13.
Autor:
Greig JA; Gene Therapy Program, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Jennis M; Gene Therapy Program, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Dandekar A; Gene Therapy Program, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Chorazeczewski JK; Gene Therapy Program, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Param N; Gene Therapy Program, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., So M; Gene Therapy Program, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Nayal M; Gene Therapy Program, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Bell P; Gene Therapy Program, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Coughlan K; Moderna, Inc., Cambridge, Massachusetts, USA., Choi M; Moderna, Inc., Cambridge, Massachusetts, USA., Giangrande PH; Moderna, Inc., Cambridge, Massachusetts, USA., Martini PGV; Moderna, Inc., Cambridge, Massachusetts, USA., Wilson JM; Gene Therapy Program, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Publikováno v:
Human gene therapy [Hum Gene Ther] 2024 Sep; Vol. 35 (17-18), pp. 726-733. Date of Electronic Publication: 2024 Aug 05.
Autor:
Greig JA; Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Martins KM; Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Breton C; Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Lamontagne RJ; Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Zhu Y; Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., He Z; Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., White J; Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Zhu JX; Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Chichester JA; Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Zheng Q; Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Zhang Z; Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Bell P; Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Wang L; Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Wilson JM; Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. wilsonjm@upenn.edu.
Publikováno v:
Nature biotechnology [Nat Biotechnol] 2024 Aug; Vol. 42 (8), pp. 1232-1242. Date of Electronic Publication: 2023 Nov 06.
Autor:
Greig JA; Agricultural Leadership, Education and Communications, The University of Tennessee, Knoxville, Tennessee, United States of America., Rampold S; Agricultural Leadership, Education and Communications, The University of Tennessee, Knoxville, Tennessee, United States of America., Paskewitz E; Agricultural Leadership, Education and Communications, The University of Tennessee, Knoxville, Tennessee, United States of America.; The Department of Communication Studies, The University of Tennessee, Knoxville, Tennessee, United States of America., Ruth T; Agricultural Leadership, Education and Communications, The University of Tennessee, Knoxville, Tennessee, United States of America.
Publikováno v:
PloS one [PLoS One] 2024 Jun 14; Vol. 19 (6), pp. e0304793. Date of Electronic Publication: 2024 Jun 14 (Print Publication: 2024).
Autor:
Hordeaux J; Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Lamontagne RJ; Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Song C; Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Buchlis G; Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Dyer C; Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Buza EL; Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Ramezani A; Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Wielechowski E; Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Greig JA; Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Chichester JA; Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Bell P; Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Wilson JM; Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. Electronic address: wilsonjm@upenn.edu.
Publikováno v:
Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2024 Apr 03; Vol. 32 (4), pp. 952-968. Date of Electronic Publication: 2024 Feb 06.
Autor:
Kistner A; Ultragenyx Pharmaceutical Inc., Novato, CA, USA., Chichester JA; Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Wang L; Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Calcedo R; Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Affinia Therapeutics, Waltham, MA, USA., Greig JA; Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Cardwell LN; Ultragenyx Gene Therapy, Ultragenyx Pharmaceutical Inc., Cambridge, MA, USA., Wright MC; Ultragenyx Pharmaceutical Inc., Novato, CA, USA., Couthouis J; Ultragenyx Pharmaceutical Inc., Novato, CA, USA., Sethi S; Charles River Laboratories Inc., Reno, NV, USA., McIntosh BE; Labcorp Drug Development, Madison, WI, USA., McKeever K; Ultragenyx Pharmaceutical Inc., Novato, CA, USA., Wadsworth S; Ultragenyx Gene Therapy, Ultragenyx Pharmaceutical Inc., Cambridge, MA, USA., Wilson JM; Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Kakkis E; Ultragenyx Pharmaceutical Inc., Novato, CA, USA., Sullivan BA; Ultragenyx Pharmaceutical Inc., Novato, CA, USA. bsullivan@ultragenyx.com.
Publikováno v:
Gene therapy [Gene Ther] 2024 Mar; Vol. 31 (3-4), pp. 128-143. Date of Electronic Publication: 2023 Oct 13.
Autor:
Martins KM; Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Breton C; Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Zheng Q; Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Zhang Z; Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Latshaw C; Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Greig JA; Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Wilson JM; Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Publikováno v:
Human gene therapy [Hum Gene Ther] 2023 Nov; Vol. 34 (21-22), pp. 1081-1094. Date of Electronic Publication: 2023 Nov 06.
Autor:
Greig JA; Gene Therapy Program, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Chorazeczewski JK; Gene Therapy Program, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Chowdhary V; Gene Therapy Program, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Smith MK; Gene Therapy Program, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Jennis M; Gene Therapy Program, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Tarrant JC; Gene Therapy Program, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Buza EL; Gene Therapy Program, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Coughlan K; Moderna, Inc., Cambridge, MA, USA., Martini PGV; Moderna, Inc., Cambridge, MA, USA., Wilson JM; Gene Therapy Program, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Publikováno v:
Molecular therapy. Methods & clinical development [Mol Ther Methods Clin Dev] 2023 Feb 15; Vol. 29, pp. 32-39. Date of Electronic Publication: 2023 Feb 15 (Print Publication: 2023).
Autor:
Horiuchi M, Hinderer CJ, Greig JA, Dyer C, Buza EL, Bell P, Chichester JA, Hayashi PM, Yan H, Goode T, Wilson JM
Publikováno v:
Molecular therapy. Methods & clinical development [Mol Ther Methods Clin Dev] 2022 Nov 12; Vol. 27, pp. 450-451. Date of Electronic Publication: 2022 Nov 12 (Print Publication: 2022).
Autor:
Greig JA; Gene Therapy Program, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Breton C; Gene Therapy Program, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Ashley SN; Gene Therapy Program, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Martins KM; Gene Therapy Program, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Gorsuch C; Precision BioSciences, Inc., Durham, North Carolina, USA., Chorazeczewski JK; Gene Therapy Program, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Furmanak T; Gene Therapy Program, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Smith MK; Gene Therapy Program, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Zhu Y; Gene Therapy Program, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Bell P; Gene Therapy Program, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Shoop W; Precision BioSciences, Inc., Durham, North Carolina, USA., Li H; Precision BioSciences, Inc., Durham, North Carolina, USA., Smith J; Precision BioSciences, Inc., Durham, North Carolina, USA., Tomberlin G; Precision BioSciences, Inc., Durham, North Carolina, USA., Clark P; Gene Therapy Program, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Mitchell TW; Gene Therapy Program, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Buza EL; Gene Therapy Program, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Yan H; Gene Therapy Program, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Jantz D; Precision BioSciences, Inc., Durham, North Carolina, USA., Wilson JM; Gene Therapy Program, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Publikováno v:
Human gene therapy [Hum Gene Ther] 2022 Nov; Vol. 33 (21-22), pp. 1174-1186.